Sally C. Pipes
Commentary
Trump Puts Drug Pricing Program Fraudsters on Notice
The Trump administration is ramping up its fight against waste, fraud, and abuse in healthcare. And that effort could help make care more affordable for millions of Americans. One of its latest targets is the 340B Drug Pricing Program, a little-known federal initiative that has warped the prescription drug market. ...
Commentary
Germany Wants Cheaper Drugs—And Americans To Pay The Difference
What does a new healthcare reform effort in Germany have to do with American patients? Quite a lot, actually. The German government is looking to cut healthcare spending by tens of billions of euros. To that end, it is pushing pharmaceutical companies to accept significantly lower prices for new medicines. ...
Commentary
Just take the shot: A simple way to protect freedom and prevent lockdowns
The mixed messages on vaccines are backfiring. Measles is surging across the South, and Georgians will pay the price. Disease outbreaks restrict personal freedom more than any government policy: schools close, families quarantine, and communities isolate. Even as the Trump administration now urges vaccination, confusion lingers. Georgia leaders must provide ...
Commentary
A lawsuit that may kill tomorrow’s cures
On Wednesday, May 6, the California Supreme Court will hear a case that could upend the economics of medical innovation. Roughly 24,000 plaintiffs are suing pharmaceutical company Gilead over one of its HIV drugs. They do not claim that the drug failed to work, nor that it was defectively manufactured, ...
Commentary
Can You Sue A Drug Company For Not Inventing Faster?
This week, the California Supreme Court is set to hear a case that could have far-reaching consequences for medical science. At issue is Gilead Sciences’ HIV treatment tenofovir disoproxil fumarate, or TDF. Tens of thousands of plaintiffs allege they suffered side effects while taking the drug. They are not arguing ...
Commentary
Breaking Up ‘Big Medicine’ Won’t Fix What Washington Broke
Washington is gearing up to crack down on “Big Medicine,” with populist Sens. Elizabeth Warren, D-Mass., and Josh Hawley, R-Mo., leading the charge. Over the past decade, America’s healthcare system has become increasingly consolidated, leaving patients with higher prices, fewer choices, and more bureaucratic frustration. But before lawmakers swing a ...
Commentary
Don’t penalize patients for shopping smart on drugs — reward them
Patients shouldn’t be penalized for finding a better deal on their prescriptions. Too often, they are. Those who pay out of pocket for medications — often at lower prices through direct-to-consumer platforms — typically receive no credit toward their health plan’s annual deductible. Higher-priced drugs purchased through an insurer’s preferred ...
Commentary
Some Never Learn: Dems’ Healthcare Repeats Same Mistakes
Democrats are laying the groundwork for their next healthcare overhaul if they take control of Congress in this fall’s elections. A new report from the Center for American Progress shows exactly what they have in mind, and patients won’t like it. The group has long served as a policy incubator ...
Commentary
Democrats Didn’t Discover The Insurance Crisis. They Created It
Sen. Ron Wyden, D-Ore., recently invited his colleagues to begin a new conversation about reforming the health insurance industry. It’s a conversation worth having. Health insurers have grown bigger, more powerful and more deeply embedded in our healthcare system than ever before—to the detriment of patients and taxpayers alike. But ...
Commentary
Obamacare Crushed Choice. This Reform Helps Restore It
Every fall, millions of Americans log onto the Affordable Care Act’s exchanges hoping to find a health plan that fits their needs. This year, roughly 23 million people have signed up through the marketplaces. Many are discovering that their options all look more or less the same—expensive and ill-suited to ...
Trump Puts Drug Pricing Program Fraudsters on Notice
The Trump administration is ramping up its fight against waste, fraud, and abuse in healthcare. And that effort could help make care more affordable for millions of Americans. One of its latest targets is the 340B Drug Pricing Program, a little-known federal initiative that has warped the prescription drug market. ...
Germany Wants Cheaper Drugs—And Americans To Pay The Difference
What does a new healthcare reform effort in Germany have to do with American patients? Quite a lot, actually. The German government is looking to cut healthcare spending by tens of billions of euros. To that end, it is pushing pharmaceutical companies to accept significantly lower prices for new medicines. ...
Just take the shot: A simple way to protect freedom and prevent lockdowns
The mixed messages on vaccines are backfiring. Measles is surging across the South, and Georgians will pay the price. Disease outbreaks restrict personal freedom more than any government policy: schools close, families quarantine, and communities isolate. Even as the Trump administration now urges vaccination, confusion lingers. Georgia leaders must provide ...
A lawsuit that may kill tomorrow’s cures
On Wednesday, May 6, the California Supreme Court will hear a case that could upend the economics of medical innovation. Roughly 24,000 plaintiffs are suing pharmaceutical company Gilead over one of its HIV drugs. They do not claim that the drug failed to work, nor that it was defectively manufactured, ...
Can You Sue A Drug Company For Not Inventing Faster?
This week, the California Supreme Court is set to hear a case that could have far-reaching consequences for medical science. At issue is Gilead Sciences’ HIV treatment tenofovir disoproxil fumarate, or TDF. Tens of thousands of plaintiffs allege they suffered side effects while taking the drug. They are not arguing ...
Breaking Up ‘Big Medicine’ Won’t Fix What Washington Broke
Washington is gearing up to crack down on “Big Medicine,” with populist Sens. Elizabeth Warren, D-Mass., and Josh Hawley, R-Mo., leading the charge. Over the past decade, America’s healthcare system has become increasingly consolidated, leaving patients with higher prices, fewer choices, and more bureaucratic frustration. But before lawmakers swing a ...
Don’t penalize patients for shopping smart on drugs — reward them
Patients shouldn’t be penalized for finding a better deal on their prescriptions. Too often, they are. Those who pay out of pocket for medications — often at lower prices through direct-to-consumer platforms — typically receive no credit toward their health plan’s annual deductible. Higher-priced drugs purchased through an insurer’s preferred ...
Some Never Learn: Dems’ Healthcare Repeats Same Mistakes
Democrats are laying the groundwork for their next healthcare overhaul if they take control of Congress in this fall’s elections. A new report from the Center for American Progress shows exactly what they have in mind, and patients won’t like it. The group has long served as a policy incubator ...
Democrats Didn’t Discover The Insurance Crisis. They Created It
Sen. Ron Wyden, D-Ore., recently invited his colleagues to begin a new conversation about reforming the health insurance industry. It’s a conversation worth having. Health insurers have grown bigger, more powerful and more deeply embedded in our healthcare system than ever before—to the detriment of patients and taxpayers alike. But ...
Obamacare Crushed Choice. This Reform Helps Restore It
Every fall, millions of Americans log onto the Affordable Care Act’s exchanges hoping to find a health plan that fits their needs. This year, roughly 23 million people have signed up through the marketplaces. Many are discovering that their options all look more or less the same—expensive and ill-suited to ...